deferoxamine has been researched along with Cognition Disorders in 6 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pneumococcal meningitis is associated with the highest fatality case ratios in the world." | 1.38 | Antioxidant treatment prevents cognitive impairment and oxidative damage in pneumococcal meningitis survivor rats. ( Barichello, T; Comim, CM; Dal-Pizzol, F; Generoso, JS; Michelon, CM; Mina, F; Otaran, P; Quevedo, J; Santos, AL; Savi, GD; Steckert, AV, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| LeBlanc, RH | 1 |
| Chen, R | 1 |
| Selim, MH | 1 |
| Hanafy, KA | 1 |
| Li, Y | 1 |
| Pan, K | 1 |
| Chen, L | 1 |
| Ning, JL | 1 |
| Li, X | 1 |
| Yang, T | 1 |
| Terrando, N | 1 |
| Gu, J | 1 |
| Tao, G | 1 |
| Barichello, T | 1 |
| Santos, AL | 1 |
| Savi, GD | 1 |
| Generoso, JS | 1 |
| Otaran, P | 1 |
| Michelon, CM | 1 |
| Steckert, AV | 1 |
| Mina, F | 1 |
| Comim, CM | 1 |
| Dal-Pizzol, F | 1 |
| Quevedo, J | 1 |
| Treadwell, MJ | 1 |
| Law, AW | 1 |
| Sung, J | 1 |
| Hackney-Stephens, E | 1 |
| Quirolo, K | 1 |
| Murray, E | 1 |
| Glendenning, GA | 1 |
| Vichinsky, E | 1 |
| Powars, DR | 1 |
| Wong, WY | 1 |
| Vachon, LA | 1 |
| Sprague, SM | 1 |
| Corwin, HL | 1 |
| Tanner, CM | 1 |
| Wilson, RS | 1 |
| Green, BJ | 1 |
| Goetz, CG | 1 |
6 other studies available for deferoxamine and Cognition Disorders
| Article | Year |
|---|---|
Heme oxygenase-1-mediated neuroprotection in subarachnoid hemorrhage via intracerebroventricular deferoxamine.
Topics: Animals; Calcium-Binding Proteins; Cells, Cultured; Cognition Disorders; Deferoxamine; Disease Model | 2016 |
Deferoxamine regulates neuroinflammation and iron homeostasis in a mouse model of postoperative cognitive dysfunction.
Topics: Animals; Cell Line, Transformed; Cognition Disorders; Conditioning, Psychological; Deferoxamine; Dis | 2016 |
Antioxidant treatment prevents cognitive impairment and oxidative damage in pneumococcal meningitis survivor rats.
Topics: Acetylcysteine; Animals; Antioxidants; Avoidance Learning; Behavior, Animal; Cerebral Cortex; Cognit | 2012 |
Barriers to adherence of deferoxamine usage in sickle cell disease.
Topics: Adolescent; Anemia, Sickle Cell; Caregivers; Chelation Therapy; Child; Child, Preschool; Cognition D | 2005 |
Incomplete cerebral infarctions are not silent.
Topics: Adolescent; Anemia, Sickle Cell; Blood Flow Velocity; Bone Marrow Transplantation; Brain Damage, Chr | 2001 |
Relationship of aluminum to neurocognitive dysfunction in chronic dialysis patients.
Topics: Adult; Aluminum; Body Burden; Cognition Disorders; Deferoxamine; Female; Humans; Male; Middle Aged; | 1988 |